Icon

FIRAZYR (nda022150)- (EQ 30MG BASE/3ML (EQ 10MG BASE/ML))

ICATIBANT ACETATE TAKEDA PHARMS USA
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)
Yes No
2019-Jul-15 2016-Aug-25
2018-Aug-25 None
None No
FIRAZYR is a bradykinin B2 receptor antagonist indicated for treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.
9 0 9
Total Other Developers 16
Drugs with Suitability No
EQ 30MG BASE/3ML (EQ 10MG BASE/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ********* **** *** ********* **** ******* *********** ************* ** ** ** *********** *, ****, ********, ******* ****, ****, ******* (***) ***
****** **** ****** *** **** ************** ********** ***. *********** ** *** ******* ******, ********** ****, **** ****, *******, ****** (***) ***
****** ******** ****** *** ****** ****** *.*.* *********** *** *******, *, *********, ****** *****, ***** (***) ***
****** **** ***** ***** ** **** ***** ************** **. ***. *********** **. ****, ********* ****, ****** ****, ****** ******** *****, ****** (***) ***
****** ***** ***** ****** ******* *********** ****** **. *** - ***, *** & ***, **** ************* ***** *****, *. *. *****, ******** ****, ******** - ************* ******, ******* - ********** ********, *********, ********* ******, ***** (***) ***
****** ***** *** ******** ** *** *********** ***. ***. *** *******-*** ****** **, ** ***** ***
****** ******** ****** *** ******** *************** ***., *** *********** **** ******** **, ******, ***** ******** (**) *****, ****** ****** (***) ***
****** ***** ****** **** ******** ******* *** *********** ****** **. ** & **, *** *****, ********** *******, ***** ******, ********** ********, **********, ********* ******, ***** (***) ***
****** ***** ****** ***** ****** ************ ******* *********** ****-***, **** **: *, ** ** **, ****, *****, ***, ************, ********** ******, **********, ********* ******, ***** (***) ***
****** ******* ******* *************** ******* *********** *********** ******** ***, **** **. ****/****, ******* - *********, ****** - *****, ********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.